Physitrack is a global leader in digital physical therapy and exercise prescription technology. Founded in 2012, the company provides a cloud-based platform that enables healthcare providers to prescribe, deliver, and monitor home exercise programs for patients with musculoskeletal and neurological conditions, including Parkinson's disease[1]. The company went public on NASDAQ Stockholm in 2022 (ticker: PHYT), marking a significant milestone for the digital rehabilitation sector.
Physitrack serves over 30,000 healthcare practitioners globally and has delivered millions of exercise programs to patients in more than 80 countries[2]. The platform addresses a critical need in modern healthcare: making evidence-based rehabilitation accessible, scalable, and measurable. By combining comprehensive exercise libraries, telehealth capabilities, and robust outcome tracking, Physitrack enables clinicians to extend their reach beyond traditional clinic settings.
The company's mission centers on democratizing access to high-quality physical therapy by empowering healthcare providers with digital tools that enhance patient engagement, improve adherence, and enable data-driven clinical decision-making. This approach is particularly relevant for chronic neurological conditions like Parkinson's disease, where ongoing rehabilitation is essential for maintaining function and quality of life.
| Attribute | Details |
|---|---|
| Headquarters | London, UK / Stockholm, Sweden |
| Founded | 2012 |
| Status | Public company (NASDAQ Stockholm: PHYT) |
| Employees | ~200 |
| Practitioners | 30,000+ |
| Countries | 80+ |
| Market Focus | Digital physical therapy, telehealth, rehabilitation |
Physitrack's evolution reflects the broader digital health transformation:
The Physitrack platform represents a comprehensive digital rehabilitation solution:
Exercise Library
Custom Program Builder
Patient Mobile Application
Telehealth Integration
Compliance Tracking
Outcome Measurement Tools
Physitrack includes validated outcome measures relevant to Parkinson's disease and other neurological conditions[3][4]:
The Physitrack technology stack includes:
| Component | Description |
|---|---|
| Cloud Infrastructure | HIPAA-compliant, GDPR-compliant data storage |
| Clinician Dashboard | Web-based interface for program management |
| Patient App | Native iOS and Android applications |
| Analytics Engine | Real-time compliance and outcome analytics |
| EHR Integration | HL7 FHIR-based integration capabilities |
| API | Open API for third-party integrations |
Parkinson's disease is a key clinical focus for Physitrack, given the substantial evidence supporting exercise as a core component of disease management[5][6]. The platform addresses multiple rehabilitation needs:
The Physitrack platform enables clinicians to prescribe comprehensive home exercise programs for PD patients:
Gait Training
Research has demonstrated that cueing strategies, including visual and auditory cues, can significantly improve gait in PD patients. The Physitrack platform supports multiple cueing modalities that can be customized to individual patient preferences and needs.
Balance Exercises
Balance-specific training reduces fall risk and improves postural stability. A systematic review found that balance training programs reduce falls by 40-50% in community-dwelling older adults, with similar benefits observed in PD populations.
Strength Training
Flexibility
Physitrack's telehealth capabilities are particularly valuable for PD patients:
Telehealth-delivered physical therapy has been validated as effective for PD, with studies showing equivalent outcomes to in-person delivery for both assessment and intervention. The Physitrack platform supports these telehealth capabilities with integrated video conferencing and real-time exercise monitoring.
The platform enables clinicians to monitor patient progress between visits:
Long-term remote monitoring has become increasingly important in Parkinson's disease management, where symptom fluctuation and disease progression require ongoing attention.
The clinical evidence supporting exercise in Parkinson's disease is robust and continues to grow[7][8]:
Motor Function
Multiple systematic reviews and meta-analyses have demonstrated that exercise improves motor function in PD. Exercise interventions significantly improve Unified Parkinson's Disease Rating Scale (UPDRS) motor scores, with effects comparable to some pharmacological interventions.
Balance and Falls
Balance-specific training reduces fall risk and improves postural stability. Tai Chi has demonstrated particular effectiveness for balance improvement in PD patients[9].
Quality of Life
Exercise improves both physical and psychological aspects of quality of life in PD. Benefits include improved mood, reduced fatigue, and enhanced ability to perform daily activities.
Neuroplasticity
Evidence from animal models and human neuroimaging studies suggests that exercise promotes neuroplasticity in the PD brain. Structural MRI studies have shown increased brain volume in exercise-trained PD patients compared to controls, suggesting exercise may slow neurodegeneration.
Disease Modification
While definitive evidence for disease modification remains limited, biomarker studies suggest that exercise may slow progression. Animal models demonstrate neuroprotective effects, and human studies show preserved dopaminergic function in exercising patients[10].
The field of digital therapeutics for rehabilitation has grown rapidly:
Home-Based Exercise
Randomized controlled trials have shown that home-based exercise programs are non-inferior to in-person therapy for improving motor function. Digital platforms enable higher exercise dose (more total exercise time) while maintaining clinical outcomes.
Telehealth Effectiveness
Telehealth-delivered physical therapy has been validated as effective for various conditions, with studies showing equivalent outcomes to in-person delivery for both assessment and intervention.
Adherence Benefits
Digital health interventions improve exercise adherence through features including goal-setting, progress feedback, reminders, and gamification. Studies show that digital platforms can significantly increase exercise adherence compared to traditional approaches.
Continuous Monitoring
Remote monitoring enables detection of subtle changes that might be missed in between clinical visits, allowing for earlier intervention and treatment adjustment.
Physitrack has demonstrated effectiveness through:
Physitrack operates in the digital rehabilitation space alongside several competitors:
| Company | Approach | Key Features |
|---|---|---|
| Hinge Health | Employer-focused digital MSK | Exercise coaching, biometrics |
| Kaia Health | Digital therapeutics | Exercise programs, respiratory training |
| SWORD Health | AI-powered physical therapy | Motion sensing, exercise guidance |
| WebPT | Physical therapy EMR | Documentation, billing, scheduling |
| Therabill | PT-specific billing | Practice management |
Physitrack differentiates through:
The addressable market for Physitrack includes:
Digital Rehabilitation Market
Parkinson's Disease Rehabilitation
Musculoskeletal Market
Successful implementation requires:
Current reimbursement landscape:
Near-term development priorities include:
Growth strategies include:
Clinical development focus areas:
Physitrack maintains robust data security standards:
Patient privacy is protected through:
The platform operates under applicable regulatory frameworks:
Digital rehabilitation platforms like Physitrack offer potential cost savings:
Physitrack aligns with value-based care priorities:
Relevant reimbursement codes for Physitrack-enabled care:
Patients using Physitrack report:
Some patients face challenges:
Physitrack serves research needs through:
A large NHS trust in the United Kingdom implemented Physitrack across its physiotherapy services:
A major US physical therapy network deployed Physitrack for post-surgical rehabilitation:
A specialized movement disorder clinic used Physitrack for PD patients:
Future AI-powered features include:
Emerging technologies being evaluated:
Expanded sensor capabilities:
Physitrack has potential to address healthcare disparities:
Potential applications in population health:
Physitrack represents a comprehensive digital health solution for physical therapy and rehabilitation. By combining an extensive exercise library, telehealth capabilities, robust outcome tracking, and seamless EHR integration, the platform addresses critical needs in modern healthcare delivery.
For neurological conditions like Parkinson's disease, where ongoing rehabilitation is essential for maintaining function and quality of life, Physitrack provides a scalable approach that extends the reach of clinicians and empowers patients to actively participate in their care. The clinical evidence supporting exercise as a core component of Parkinson's disease management, combined with the platform's robust feature set, positions Physitrack as a valuable tool in the digital therapeutics landscape.
The company's public market status and global reach indicate a mature platform with proven capabilities. As digital health continues to evolve, Physitrack's focus on evidence-based practice, regulatory compliance, and patient outcomes positions it well for continued growth and impact in the rehabilitation space.
Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev. 2013. ↩︎
Keus SHJ, Bloem BR, Hendriks EJM, et al. Evidence-based physical therapy for Parkinson's disease. Mov Disord. 2014. ↩︎
Shulman LM, Katzel LI, Ivey FM, et al. Parkinson's disease exercise interventions and disease modification. JAMA Neurol. 2013. ↩︎
Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015. ↩︎
Sacco G, Pica G, Sconfienza LM, et al. Exercise and Parkinson's disease evidence-based review. J Parkinsons Dis. 2016. ↩︎
Uhr M, Chahine L, Shulman L. Exercise and Parkinson's disease. Nat Rev Neurol. 2020. ↩︎
Li F, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson's disease. N Engl J Med. 2012. ↩︎
Petersen MS, Honson K, Wang F, et al. Exercise and Parkinson's disease mechanisms and clinical trials. Mov Disord. 2018. ↩︎